Inozyme Pharma Announces Three Poster Presentations at the American Society for Bone and Mineral Research (ASBMR) 2023 Annual Meeting
BOSTON, Oct. 06, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY) (“Inozyme” or the “Company”),…
News
Inozyme Pharma Announces Three Poster Presentations at the American Society for Bone and Mineral Research (ASBMR) 2023 Annual Meeting
BOSTON, Oct. 06, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY) (“Inozyme” or the “Company”),…
Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro Summit
IRVINE, Calif., Oct. 06, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical…
Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro Summit
IRVINE, Calif., Oct. 06, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical…
IMUNON Appoints Dr. Patrick Ott to its Scientific Advisory Board
Renowned Daner-Farber Cancer Institute researcher will advise on the development of IMUNON’s FixPlas™ and Indiplas™…
IMUNON Appoints Dr. Patrick Ott to its Scientific Advisory Board
Renowned Daner-Farber Cancer Institute researcher will advise on the development of IMUNON’s FixPlas™ and Indiplas™…
Aditxt, Inc. to Present at 8th Annual Dawson James Conference
Chief Executive Officer, Amro Albanna to Present at 9:00am Eastern Time on Thursday, October 12,…
Aditxt, Inc. to Present at 8th Annual Dawson James Conference
Chief Executive Officer, Amro Albanna to Present at 9:00am Eastern Time on Thursday, October 12,…
Ocuphire Pharma to Present at Euretina and Retina Society Conferences in October
Presentations Will Feature Data From ZETA-1 Phase 2 Trial of APX3330 in Diabetic Retinopathy FARMINGTON…
Ocuphire Pharma to Present at Euretina and Retina Society Conferences in October
Presentations Will Feature Data From ZETA-1 Phase 2 Trial of APX3330 in Diabetic Retinopathy FARMINGTON…
Locanabio Announces Presentation of Preclinical Data Demonstrating an Improved Vectorized snRNA Platform with Applications in Exon Skipping for the Potential Treatment of Duchenne Muscular Dystrophy (DMD) at the 28th Annual Congress of the World Muscle Society (WMS2023)
Locanabio expects to submit IND application in mid-2024 for first program, LBIO-115, designed to promote…
Locanabio Announces Presentation of Preclinical Data Demonstrating an Improved Vectorized snRNA Platform with Applications in Exon Skipping for the Potential Treatment of Duchenne Muscular Dystrophy (DMD) at the 28th Annual Congress of the World Muscle Society (WMS2023)
Locanabio expects to submit IND application in mid-2024 for first program, LBIO-115, designed to promote…
FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for Treatment of Psoriasis in Children Ages 6 to 11
Expanded indication for ZORYVE provides new, steroid-free topical for children 6 to 11 with plaque…
FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for Treatment of Psoriasis in Children Ages 6 to 11
Expanded indication for ZORYVE provides new, steroid-free topical for children 6 to 11 with plaque…
Lowell Farms Inc. Announces Repurchase of $22 Million of Senior Secured Convertible Debentures
California cannabis leader repurchases all outstanding senior secured convertible indebtedness SALINAS, Calif., Oct. 06, 2023…
Lowell Farms Inc. Announces Repurchase of $22 Million of Senior Secured Convertible Debentures
California cannabis leader repurchases all outstanding senior secured convertible indebtedness SALINAS, Calif., Oct. 06, 2023…
LSL Pharma Group Engages Paradox as Investor Relations Services Provider
BOUCHERVILLE, Québec, Oct. 06, 2023 (GLOBE NEWSWIRE) — LSL Pharma Group Inc. (TSXV: LSL) –…
LSL Pharma Group Engages Paradox as Investor Relations Services Provider
BOUCHERVILLE, Québec, Oct. 06, 2023 (GLOBE NEWSWIRE) — LSL Pharma Group Inc. (TSXV: LSL) –…
Immunocore announces upcoming presentation and posters at ESMO 2023
Immunocore announces upcoming presentation and posters at ESMO 2023 Long-term survival data for KIMMTRAK in…
FOXO Technologies™ Interim CEO Mark White Provides Letter to Shareholders Outlining New AI-Enabled Direct-to-Consumer Strategy and Immediate Expense Reductions
MINNEAPOLIS–(BUSINESS WIRE)–FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”), a leader in the…